HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.

Abstract
Ischemia/reperfusion injury (IRI) is a central phenomenon in kidney transplantation and AKI. Integrity of the renal peritubular capillary network is an important limiting factor in the recovery from IRI. MicroRNA-126 (miR-126) facilitates vascular regeneration by functioning as an angiomiR and by modulating mobilization of hematopoietic stem/progenitor cells. We hypothesized that overexpression of miR-126 in the hematopoietic compartment could protect the kidney against IRI via preservation of microvascular integrity. Here, we demonstrate that hematopoietic overexpression of miR-126 increases neovascularization of subcutaneously implanted Matrigel plugs in mice. After renal IRI, mice overexpressing miR-126 displayed a marked decrease in urea levels, weight loss, fibrotic markers, and injury markers (such as kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin). This protective effect was associated with a higher density of the peritubular capillary network in the corticomedullary junction and increased numbers of bone marrow-derived endothelial cells. Hematopoietic overexpression of miR-126 increased the number of circulating Lin(-)/Sca-1(+)/cKit(+) hematopoietic stem and progenitor cells. Additionally, miR-126 overexpression attenuated expression of the chemokine receptor CXCR4 on Lin(-)/Sca-1(+)/cKit(+) cells in the bone marrow and increased renal expression of its ligand stromal cell-derived factor 1, thus favoring mobilization of Lin(-)/Sca-1(+)/cKit(+) cells toward the kidney. Taken together, these results suggest overexpression of miR-126 in the hematopoietic compartment is associated with stromal cell-derived factor 1/CXCR4-dependent vasculogenic progenitor cell mobilization and promotes vascular integrity and supports recovery of the kidney after IRI.
AuthorsRoel Bijkerk, Coen van Solingen, Hetty C de Boer, Pieter van der Pol, Meriem Khairoun, Ruben G de Bruin, Annemarie M van Oeveren-Rietdijk, Ellen Lievers, Nicole Schlagwein, Danielle J van Gijlswijk, Marko K Roeten, Zeinab Neshati, Antoine A F de Vries, Mark Rodijk, Karin Pike-Overzet, Yascha W van den Berg, Eric P van der Veer, Henri H Versteeg, Marlies E J Reinders, Frank J T Staal, Cees van Kooten, Ton J Rabelink, Anton Jan van Zonneveld
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 25 Issue 8 Pg. 1710-22 (Aug 2014) ISSN: 1533-3450 [Electronic] United States
PMID24610930 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 by the American Society of Nephrology.
Chemical References
  • Chemokine CXCL12
  • MIRN126 microRNA, mouse
  • MicroRNAs
  • Receptors, CXCR4
Topics
  • Acute Kidney Injury (metabolism, pathology, prevention & control)
  • Animals
  • Cell Movement (physiology)
  • Chemokine CXCL12 (metabolism)
  • Hematopoietic Stem Cells (physiology)
  • Kidney (blood supply, metabolism, pathology)
  • Male
  • Mice, Inbred C57BL
  • MicroRNAs (physiology)
  • Neovascularization, Physiologic (physiology)
  • Receptors, CXCR4 (metabolism)
  • Reperfusion Injury (metabolism, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: